Related Content
-
PrEP--Expanding the HIV Prevention Toolkit
-
By Laura Perkins, MLS | December 4, 2015
PrEP (pre-exposure prophylaxis) for HIV means taking a combination pill to prevention transmission of the virus. The pill, brand name Truvada, has proved to be successful at protecting at-risk individuals. Trials evaluating PrEP among gay and bisexual men, heterosexual men and women, and injection drug users indicate that the risk of getting HIV decreased by up to 92% for participants who took the medicine consistently.
This is phenomenal!
- Read More
Related Content
Now in Spanish--Using PrEP to Prevent HIV
By Laura Perkins, MLS | February 18, 2016
Project Editor, ETR
The Hispanic/Latino community is disproportionately affected by HIV. In 2013, Hispanics/Latinos accounted for 21% of the estimated new diagnoses of HIV infection in the U.S., despite representing about 17% of the total population.
We recently reported how pleased we are that ETR has a new pamphlet on PrEP (pre-exposure prophylaxis) to prevent HIV. Well, now we're especially thrilled to offer our new title on PrEP in Spanish.
Increase Access, Decrease Stigma
Young Latino men who have sex with men (MSM) are lagging behind in PrEP uptake, possibly because of a lack of equal access to resources, possibly because of HIV-related stigma.
Our new pamphlet presents information about PrEP in a clear, accessible, nonjudgmental way. People want to know if PrEP is a good option for them. They want to know how to go about asking a provider for PrEP and how to pay for treatment. "¿Le serviría la PrEP?" answers these and other essential questions.
Trials evaluating PrEP among MSM, heterosexual men and women, and injection drug users indicate that the risk of getting HIV was up to 92% lower for participants who took the medicine consistently. PrEP needs to be made accessible and de-stigmatized for all people at high risk in order to fulfill its promise as a powerful HIV prevention tool.
